MoKaRi II Intervention Study
MoKaRi II
Modulation of Cardiovascular Risk II (MoKaRi II) Intervention Study - Modulation of Cardiovascular Risk and Diabetes Risk Using Menu Plans
1 other identifier
interventional
120
1 country
1
Brief Summary
The proposed intervention study addresses the development and validation of nutritional concepts based on menu plans for patients with hypertriglyceridemia (triglycerides \> 1.5 mmol/l) and participants with impaired glucose tolerance/prediabetes (glucose \> 5.6 ≤ 7 mmol/l).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2022
CompletedFirst Posted
Study publicly available on registry
May 19, 2022
CompletedStudy Start
First participant enrolled
May 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 14, 2022
CompletedFebruary 6, 2023
February 1, 2023
3 months
May 16, 2022
February 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Triacylglcerides, mmol/l (group A, B)
Cardiovascular risk factor
Change from baseline after 10 weeks
Fasting glucose, mmol/l (group C, D)
Diabetes risk factor
Change from baseline after 10 weeks
Secondary Outcomes (28)
Total cholesterol (mmol/l)
Change from baseline after 10 weeks
HDL cholesterol (mmol/l)
Change from baseline after 10 weeks
LDL cholesterol (mmol/l)
Change from baseline after 10 weeks
Systolic pressure (mm Hg)
Change from baseline after 10 weeks
Diastolic pressure (mm Hg)
Change from baseline after 10 weeks
- +23 more secondary outcomes
Other Outcomes (4)
Creatinine (mmol/l)
Change from baseline after 10 weeks
Albumine (mg/l)
Change from baseline after 10 weeks
Selenium (µmol/24 h)
Change from baseline after 10 weeks
- +1 more other outcomes
Study Arms (4)
Hypertriglyceridemia intervention (group A)
EXPERIMENTAL* Carbohydrates: ≤ 50 en% (sucrose + glucose + fructose ≤ 10 en%, where sucrose ≤ 5 en% and fructose ≤ 20 g/d) * Fat: 30-35 En% * Protein: 20 En% * marine n3 PUFA (EPA/DHA): ≥ 4000 mg/d (10 g fish oil)
Hypertriglyceridemia control (group B)
NO INTERVENTIONno menu plans, no study foods
Prediabetes intervention (group C)
EXPERIMENTAL* Carbohydrates: 40 ± 2 En% * Sucrose + glucose + fructose ≤ 10 En% * Free sugars \< 5% of daily energy * Fat: 40 ± 2% * Protein: 20 ± 2 En% * n3 PUFA: ≥ 500 mg/d
Prediabetes control (group D)
NO INTERVENTIONno menu plans, no study foods
Interventions
The study participants in group A and C receive defined personal nutritional counselling every two weeks and they are provided with daily menu plans (isocaloric) with optimized nutrient profiles and chosen study products (plant oils, nuts mixture etc.) over the study period of 10 weeks.
Eligibility Criteria
You may qualify if:
- Voluntary participation with documented consent
- Willingness and ability to adhere to study protocol
- Volunteer test person (m/f) aged ≥ 30 years and ≤ 80 years
- BMI: ≥ 20 ≤ 40 kg/m2
- No or moderate alcohol consumption (≤ 2 glasses/week)
- non-smoker (if possible)
- Group A, B: triglycerides: \> 1.5 mmol/l
- Group C, D: Fasting glucose: ≥ 5.6 ≤ 7 mmol/L
You may not qualify if:
- Concomitant diseases:
- Hypercholesterolemia (genetic defect / familial predisposition)
- Diabetes mellitus
- Thyroid dysfunction (hyper- or hypothyroidism)
- Food intolerances/allergies to ingredients in the study foods
- Medications: lipid-lowering drugs, glucocorticoids, oral medication for the treatment of type 1-4 diabetes mellitus, insulin injections
- Dietary supplements: especially n-3 fatty acids, vitamin E
- Extremely high physical activity (daily)
- Alcohol abuse (daily)
- (smokers) \[if there are not enough subjects available, at least 7 smokers should be included so that a statistical analysis is possible\]
- Uncontrolled organic diseases
- Alcohol, medication or drug abuse
- Participation in other observational clinical studies during or 4 wk. before starting this study
- Severe behavioral, emotional, or psychiatric problems that the investigator determined would result in non-compliance
- Pregnancy, lactation and unsafe contraception
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Nutritional Sciences
Jena, Thuringia, 07743, Germany
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christine A Dawczynski, PhD
Friedrich Schiller University Jena
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
May 16, 2022
First Posted
May 19, 2022
Study Start
May 30, 2022
Primary Completion
August 31, 2022
Study Completion
December 14, 2022
Last Updated
February 6, 2023
Record last verified: 2023-02